These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 29616037)

  • 1. MicroRNA Roles in the Nuclear Factor Kappa B Signaling Pathway in Cancer.
    Wu J; Ding J; Yang J; Guo X; Zheng Y
    Front Immunol; 2018; 9():546. PubMed ID: 29616037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?
    Mirzaei S; Zarrabi A; Hashemi F; Zabolian A; Saleki H; Ranjbar A; Seyed Saleh SH; Bagherian M; Sharifzadeh SO; Hushmandi K; Liskova A; Kubatka P; Makvandi P; Tergaonkar V; Kumar AP; Ashrafizadeh M; Sethi G
    Cancer Lett; 2021 Jul; 509():63-80. PubMed ID: 33838282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA and NF-kappa B.
    Yuan Y; Tong L; Wu S
    Adv Exp Med Biol; 2015; 887():157-70. PubMed ID: 26662991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noncoding RNAs Regulating NF-κB Signaling.
    Li M; Guan H
    Adv Exp Med Biol; 2016; 927():317-36. PubMed ID: 27376741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3.
    Zhao N; Wang R; Zhou L; Zhu Y; Gong J; Zhuang SM
    Mol Cancer; 2014 Feb; 13():35. PubMed ID: 24565101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-192/NKRF axis confers lung cancer cell chemoresistance to cisplatin via the NF-κB pathway.
    Li Y; Zu L; Wu H; Zhang F; Fan Y; Pan H; Du X; Guo F; Zhou Q
    Thorac Cancer; 2022 Feb; 13(3):430-441. PubMed ID: 34953057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classic and Novel Signaling Pathways Involved in Cancer: Targeting the NF-κB and Syk Signaling Pathways.
    Tang C; Zhu G
    Curr Stem Cell Res Ther; 2019; 14(3):219-225. PubMed ID: 30033874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The complexity of NF-κB signaling in inflammation and cancer.
    Hoesel B; Schmid JA
    Mol Cancer; 2013 Aug; 12():86. PubMed ID: 23915189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear factor-κB-dependent microRNA-130a upregulation promotes cervical cancer cell growth by targeting phosphatase and tensin homolog.
    Feng Y; Zhou S; Li G; Hu C; Zou W; Zhang H; Sun L
    Arch Biochem Biophys; 2016 May; 598():57-65. PubMed ID: 27040383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-127-5p targets the biliverdin reductase B/nuclear factor-κB pathway to suppress cell growth in hepatocellular carcinoma cells.
    Huan L; Bao C; Chen D; Li Y; Lian J; Ding J; Huang S; Liang L; He X
    Cancer Sci; 2016 Mar; 107(3):258-66. PubMed ID: 26708147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic microRNAs targeting the NF-kappa B signaling circuits of cancers.
    Tong L; Yuan Y; Wu S
    Adv Drug Deliv Rev; 2015 Jan; 81():1-15. PubMed ID: 25220353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of cell death and autophagy by IKK and NF-κB: critical mechanisms in immune function and cancer.
    Baldwin AS
    Immunol Rev; 2012 Mar; 246(1):327-45. PubMed ID: 22435564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs in NF-kappaB signaling.
    Ma X; Becker Buscaglia LE; Barker JR; Li Y
    J Mol Cell Biol; 2011 Jun; 3(3):159-66. PubMed ID: 21502305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of NF-κB signaling unveils novel strategies to overcome drug resistance in cancers.
    Li Y; Zhao B; Peng J; Tang H; Wang S; Peng S; Ye F; Wang J; Ouyang K; Li J; Cai M; Chen Y
    Drug Resist Updat; 2024 Mar; 73():101042. PubMed ID: 38219532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-145-5p Suppresses Tumor Cell Migration, Invasion and Epithelial to Mesenchymal Transition by Regulating the Sp1/NF-κB Signaling Pathway in Esophageal Squamous Cell Carcinoma.
    Mei LL; Wang WJ; Qiu YT; Xie XF; Bai J; Shi ZZ
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28832500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Pathways: The Balance between Cancer and the Immune System Challenges the Therapeutic Specificity of Targeting Nuclear Factor-κB Signaling for Cancer Treatment.
    Zeligs KP; Neuman MK; Annunziata CM
    Clin Cancer Res; 2016 Sep; 22(17):4302-8. PubMed ID: 27422962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-27a alleviates LPS-induced acute lung injury in mice via inhibiting inflammation and apoptosis through modulating TLR4/MyD88/NF-κB pathway.
    Ju M; Liu B; He H; Gu Z; Liu Y; Su Y; Zhu D; Cang J; Luo Z
    Cell Cycle; 2018; 17(16):2001-2018. PubMed ID: 30231673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction between miRNAs/lncRNAs and nuclear factor-κB (NF-κB) in human disorders.
    Ghafouri-Fard S; Abak A; Fattahi F; Hussen BM; Bahroudi Z; Shoorei H; Taheri M
    Biomed Pharmacother; 2021 Jun; 138():111519. PubMed ID: 33756159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The functional analysis of MicroRNAs involved in NF-κB signaling.
    Yang Y; Wang JK
    Eur Rev Med Pharmacol Sci; 2016 May; 20(9):1764-74. PubMed ID: 27212168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.